|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.090 USD | +1.87% |
|
+3.91% | -65.93% |
| 08-06 | Revelation Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-10 | Revelation Biosciences Adopts Stockholder Rights Plan | MT |
Evolution of the Average Target: Revelation Biosciences, Inc.
Evolution of the Target Price: Revelation Biosciences, Inc.
Changes in Analyst Recommendations: Revelation Biosciences, Inc.
b29.gglSPliN89tW_Iz1h6odY9IiMMoOQY-IoUeWjFyWUnM.2DAhazD8sYoVtfms8dtcW4d0coBhGbfZxgjy6wTHH0bVY2tRHOuJn2GSyQ~e0b34add31ee6ad97d8a19c21a294662
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | +1,528.44% | ||||
| +15.02% | |||||
| +6.58% | |||||
| +5.91% | |||||
| +15.63% | |||||
| +38.34% | |||||
| -6.27% | |||||
| +23.52% | |||||
| -0.43% | |||||
| -4.81% | |||||
| Average | +162.19% | |||||
| Weighted average by Cap. | +12.38% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.090USD
Average target price
17.75USD
Spread / Average Target
+1,528.44%
High Price Target
19.50USD
Spread / Highest target
+1,688.99%
Low Price Target
16.00USD
Spread / Lowest Target
+1,367.89%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Roth MKM |
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.090USD
Average target price
17.75USD
Spread / Average Target
+1,528.44%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REVB Stock
- Consensus Revelation Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
